KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Long-Term Investments (2016 - 2025)

Elevance Health (ELV) has disclosed Long-Term Investments for 17 consecutive years, with $1.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments rose 24.41% to $1.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 billion, a 24.41% increase, with the full-year FY2024 number at $1.0 billion, down 83.05% from a year prior.
  • Long-Term Investments was $1.1 billion for Q3 2025 at Elevance Health, down from $10.5 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $10.5 billion in Q2 2025 to a low of $396.0 million in Q1 2021.
  • A 5-year average of $2.1 billion and a median of $610.0 million in 2023 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 1151.84% in 2024, then crashed 84.21% in 2025.
  • Elevance Health's Long-Term Investments stood at $449.0 million in 2021, then increased by 29.4% to $581.0 million in 2022, then soared by 951.12% to $6.1 billion in 2023, then plummeted by 83.05% to $1.0 billion in 2024, then rose by 7.34% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Long-Term Investments are $1.1 billion (Q3 2025), $10.5 billion (Q2 2025), and $1.1 billion (Q1 2025).